Jérôme Razanamahery Maroua Abdallahoui Guillaume Chabridon Agnès Fromont Georges Tarris Ahmed Idbaih Pierre Olivier Comby Francois Godard Julien Haroche Sylvain Audia Bernard Bonnotte
10.3389/fimmu.2022.918613
Front Immunol
2022 Jul 6;13:918613.
braf inhibitor erdheim-chester disease cerebellar syndrome histiocytosis interferon psychosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/35874752/
Delirium Erdheim-Chester Disease / diagnosis Erdheim-Chester Disease / drug therapy Erdheim-Chester Disease / genetics
Delirium Erdheim-Chester Disease / diagnosis Erdheim-Chester Disease / drug therapy Erdheim-Chester Disease / genetics Case Reports Aged, 80 and over Antiviral Agents / therapeutic use Female Humans Interferons / therapeutic use Protein Kinase Inhibitors / therapeutic use Proto-Oncogene Proteins B-raf / genetics Vemurafenib / therapeutic use Antiviral Agents Protein Kinase Inhibitors Vemurafenib Interferons BRAF protein, human Proto-Oncogene Proteins B-raf
PMC9299438
35874752
Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report
2022